Tag: tirzepatide
-
Brain recordings reveal short-lived effects of tirzepatide on food cravings
New clues on how tirzepatide affects cravings Researchers are shedding light on how tirzepatide, a drug sold as Mounjaro and Zepbound for obesity and related conditions, influences the brain’s response to food. In a rare look at brain activity during treatment, scientists observed transient shifts in the neural circuits that underlie appetite and reward. The…
-
Brain Recordings Show Short-Lived Impact of Tirzepatide on Food Cravings
New insights into tirzepatide’s neural effects In a rare peek inside the brains of people with obesity and loss of control eating, researchers used brain recordings to study how tirzepatide—a drug sold as Mounjaro and Zepbound—affects cravings. The findings, though preliminary, suggest that the medication can acutely suppress activity in brain regions tied to reward…
-
Mother’s Mounjaro weight-loss tale ends in gallbladder surgery but no regrets
Rising hopes and a difficult turn Emma McDonald, a 38-year-old British mother, turned to Mounjaro (tirzepatide) in mid-2024 after years of struggling to lose weight following pregnancy. Like many women, she battled polycystic ovary syndrome (PCOS) and significant weight gain that began after giving birth. Emma recalls feeling she had exhausted other options: “Mounjaro was…
-
British Mother’s Mounjaro Journey: A Glimmer of Weight Loss Amid Gallbladder Nightmares
Introduction: A Weight-Loss Tale Intersected by Serious Medical Complications Emma McDonald, a 38-year-old British mother, sought a path to sustainable weight loss after pregnancy-related weight gain. Turning to Mounjaro, a GLP-1 receptor agonist known for its appetite-suppressing effects, she hoped to regain control of her health and PCOS symptoms. What began as a life-changing weight-loss…
-
British Mother’s Mounjaro Fight: From Rapid Weight Loss to Gallbladder Surgery
Overview: A Weight-Loss Journey Takes a Serious Turn A British mother’s attempt to reclaim her health using the diabetes and weight-loss drug Mounjaro has been marked by dramatic results and a frightening medical complication. Emma McDonald, 38, credits the GLP-1 receptor agonist with helping her shed pounds she felt were out of reach after pregnancy,…